Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and

Eva Andreuzzi1, Albina Fejza1, Alessandra Capuano1

  • 1Department of Research and Diagnosis, Division of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.

Matrix Biology Plus
|February 5, 2021
PubMed

Insights

Gastric cancer research identifies EMILIN2 (Elastin Microfibril Interfacer 2) as a suppressed protein. Its expression impacts tumor growth, apoptosis, and vascular density, offering potential as a biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a prevalent and often fatal malignancy.
  • Targeted therapies for gastric cancer lag behind other solid tumors due to limited actionable mutations.
  • There is a critical need for novel diagnostic/prognostic biomarkers and therapeutic targets in gastric cancer.

Purpose of the Study:

  • To investigate the role of Extracellular Matrix glycoprotein EMILIN2 (Elastin Microfibril Interfacer 2) in gastric cancer.
  • To identify potential diagnostic or prognostic biomarkers for gastric carcinoma.
  • To understand EMILIN2's impact on the gastric cancer microenvironment.

Main Methods:

  • Analysis of EMILIN2 expression in a cohort of gastric cancer patients.
  • Correlation of EMILIN2 levels with vascular density.
  • Assessment of EMILIN2's effects on gastric carcinoma cell proliferation, apoptosis, and cytokine production (e.g., IL-8).

Main Results:

  • EMILIN2 expression was consistently suppressed in gastric cancer tissues.
  • High EMILIN2 levels correlated with abnormal tumor vascular density.
  • EMILIN2 demonstrated a dual role: inhibiting proliferation via apoptosis and stimulating pro-angiogenic/inflammatory cytokines like IL-8.

Conclusions:

  • EMILIN2 acts as a significant onco-regulator in gastric cancer.
  • EMILIN2 influences tumor cell behavior and the tumor microenvironment.
  • EMILIN2 warrants further investigation as a potential therapeutic target and biomarker for gastric cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K